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Abstract
The aim of this study was to determine the optimal temperature of graft preservation after
ex vivo gene transfer to rat lung isografts. Left lungs were harvested and infused with cationic
lipid/LacZ-DNA complex via the pulmonary artery, and the grafts were stored for 4h. The grafts
(n&#xFF1D;7) were allocated into groups I&#xFF9D;IV according to the storage temperature:4&#x2103;,
10&#x2103;, 16&#x2103;, and 23&#x2103;, respectively. Forty-eight h after orthotopic trans-
plantation, the arterial blood gas was analyzed and the peak airway preure (PAP) and the level of
LacZ protein production in the grafts were measured by reverse transcription polymerase chain
reaction. After reperfusion, the grafts were stained with hematoxylin and eosin. The grafts in
groups III and IV showed more deterioration as evidenced by decreased arterial oxygen tension,
increased PAP, and predominant infiltration of inflammatory cells compared with groups I and II.
The level of LacZ production was significantly lower in group I than in groups II&#xFF9D;IV.
The optimal temperature of lung graft preservation after ex vivo gene transfer was determined to
be 10&#x2103;, balancing considerations of lung injury and efficiency of transgene expreion.
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ung transplantation has become an eﬀective 
therapeutic option for selective patients with a 
variety of end-stage pulmonary diseases.  Early graft 
dysfunction resulting from ischemia-reperfusion injury 
and chronic lung dysfunction,  as manifested by bron-
chiolitis obliterans syndrome,  accounts for the major 
part of mortality and signiﬁcant morbidity after lung 
transplantation [1,  2].  Many experiments have been 
conducted with the goal of overcoming these obstacles 
[3ﾝ5],  but few have been applicable to the clinical 
situation.  A promising new approach in the ﬁeld of 
organ transplantation is the use of gene therapy.  The 
application of gene therapy to organ transplantation 
has signiﬁcant therapeutic possibilities for controlling 
adverse processes in lung transplantation.  Ex vivo 
transfection of donor organs after harvest would 
enable targeted organ-speciﬁc transgene expression,  
and this could help to prevent graft damage.  In addi-
tion,  gene therapy has the potential to eliminate 
problems associated with immunosuppression by 
allowing the production of immunomodulatory proteins 
in the donor grafts resulting in local rather than 
systemic immunosuppression [6].  Several studies 
have already supported this possibility [7,  8].
　 One of the mechanisms involved in cationic lipid-
mediated gene transfer is temperature [9],  and a 
higher incubation temperature seems to be favorable 
for transgene expression [10ﾝ12].  In this regard,  it 
L
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is desirable to keep the storage temperature high 
enough to elicit a good transfection; however,  hypo-
thermic preservation is the key to the maintenance of 
graft viability.  Therefore,  it is necessary to deter-
mine the optimal graft storage temperature in ex vivo 
gene transfection in order to apply this new modality 
in clinical settings.  In the present study,  we evaluated 
the inﬂuences among the storage temperature,  the 
graft function,  and the eﬃcacy of transgene expres-
sion in a rat lung transplantation model.
Materials and Methods
　 Plasmid expression vector and cationic lip-
ids. A eukaryotic expression vector plasmid con-
taining the ｹ-galactosidase gene,  pCMV-SPORT-ｹ
-gal (Invitrogen Corp.,  Carlsbad,  CA,  USA),  was 
used.  The plasmid contains the reporter gene ｹ
-galactosidase from Escherichia coli.  The cationic lipid 
reagent DMRIE-C (DMRIE: 1,  2-dimyristyloxypropyl-
3-dimethyl-hydroxy ethyl ammonium bromide/choles-
terol) was purchased from Invitrogen Corp.
　 Preparation of cationic lipid/DNA com-
plexes. The DNA /liposome complex for ex vivo 
administration was prepared as follows.  A 5-ｻl solu-
tion of cationic liposome containing 10ｻg of DMRIE-C 
reagent was added to 2ｻl (＝2ｻg) plasmid DNA,  
which was then diluted with saline solution to a total 
volume of 300ｻl.  We set the ratio of DMRIE-C 
reagent to plasmid DNA at 5 to 1 and the concentra-
tion of cationic lipid at 50ｻM,  according to a previous 
report [13].  The resulting complex was mixed gently 
by drawing solution into a syringe and expelling it 
back into the total volume for 3min.  The mixed solu-
tion was incubated at room temperature for 6min and 
gently injected into the left main pulmonary artery of 
the lung graft [14].
　 Animals. Male Crj: CD (SD) IGS rats weigh-
ing 240ﾝ290g (Charles River Japan Inc.  Osaka,  
Japan) were used in all experiments.  All animals 
received humane care in compliance with the 
“Principles of Laboratory Animal Care” formulated by 
the National Society for Medical Research and the 
“Guide for the Care and Use of Laboratory Animals” 
prepared by the Institute of Laboratory Animals 
Resources and published by the National Institutes of 
Health (NIH Publication No. 85ﾝ23,  revised 1985).
　 Rat lung transplantation. Donor rats were 
anesthetized,  intubated,  and heparinized and then 
underwent a median sternotomy-laparotomy.  The 
abdominal aorta,  inferior vena cava,  and left atrial 
appendage were incised,  and the lungs were ﬂushed 
through the main pulmonary artery (PA) with 20ml of 
cold (4℃) normal saline solution at 25cmH2O of pres-
sure.  After the heart-lung block was excised with the 
lungs inﬂated at end-tidal volume,  the left lung was 
dissected away.  The plasmid DNA/DMRIE-C com-
plexes were administered via the left main PA,  and 
the grafts were stored for 4h in normal saline solution 
at various temperatures: 4℃ (Group I,  n＝7),  10℃ 
(Group II,  n＝7),  16℃ (Group III,  n＝7),  and 23℃ 
(Group IV,  n＝7).  Recipient rats were anesthetized,  
intubated,  and subjected to a left thoracotomy and left 
pneumonectomy.  Subsequently the grafts were 
implanted using the cuﬀ technique [15].  Ventilation 
and perfusion to the grafts were restored,  and a chest 
tube was inserted temporarily and then removed after 
the return of spontaneous respiration.
　 Assessment. Recipient animals underwent 
median sternotomy 48h after transplantation.  After 
the ligation of the right main bronchus and the right 
main PA,  isografts only were ventilated with 100ｵ 
oxygen for 5min (tidal volume＝1.5ml,  respiratory 
rate＝100/min) while peak airway pressure (PAP) 
was measured by polygraph.  An arterial blood sample 
was drawn from the ascending aorta and blood gas 
analysis was performed,  and the left lung isografts 
were extracted and immediately ﬂushed with 20ml of 
cold PBS (－) from a height of 25cm.  The middle 
quarter of lung grafts was ﬁxed with 20ｵ formalin 
and stained with hematoxylin and eosin.  The remain-
ing lung grafts were frozen in liquid nitrogen and 
stored at －80℃ for reverse transcription-polymerase 
chain reaction (RT-PCR) assessment.
　 Quantitative RT-PCR. We measured the 
expression of lacZ mRNA by quantitative RT-PCR 
assay.  For the following reactions,  a SuperScript 
First-Strand Synthesis System for RT-PCR 
(Invitrogen Corp.) was used according to the manufac-
turerʼs instructions.  First-strand cDNA was gener-
ated by using a 20-ｻl reaction volume containing 5ｻg 
of the extracted total RNA,  10mM dNTP mix,  0.5ｻg 
per ｻl Oligo (dT),  10×RT buﬀer,  25mM MgCl2,  
0.1 molar dithiothreitol,  1ｻl RNASEOUT 
Recombinant RNase Inhibitor,  and 1ｻl (50 units) of 
SuperScript II RT.  Synthesis time was 50min at 
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42℃.  The cDNA was puriﬁed by incubation for 
20min at 37℃ with 1ｻl RNaseH.  The puriﬁed cDNA 
was used for quantitative PCR.  Quantitative PCR was 
performed in a GeneAmp 5700 Sequence Detection 
System (Applied Biosystems,  Foster City,  CA,  
USA).  Using this system,  PCR products were quan-
tiﬁed by measuring the increase in ﬂuorescence caused 
by the binding of SYBR Green dye to double-stranded 
DNA for each cycle [16].  We used 50ｻl of reaction 
mixture containing 5ｻl of the cDNA acquired by RT 
described above,  25ｻl of the 2×SYBR Green Master 
Mix (Applied Biosystems),  3ｻl sense and anti-sense 
primers (5ｻM),  and 14ｻl deionized water.  The 
ampliﬁcation program consisted of 2min at 50℃,  
10min at 95℃,  and 40 cycles involving denaturation 
at 95℃ for 15sec and annealing/extension at 60℃ 
for 1min.  A semi-quantitative value for the initial 
target concentration in each reaction was determined 
on the basis of the kinetic approach using the 
GeneAmp 5700 software.  GAPDH was used to nor-
malize LacZ expression from the same cDNA sample.
　 cDNA primers for quantitative RT-PCR.
LacZ primers for quantitative PCR were designed 
using the primer design software Primer Express 
(Applied Biosystems).  LacZ primers were designed as 
follows: sense-primer,  5ʼ-GGCAGTTATCTGGAAG
ATCAGGA-3ʼ; antisense-primer 5ʼ-CAACATGGAA
ATCGCTGATTTG-3ʼ.  Rodent GAPDH forward and 
reverse primers were purchased from Applied 
Biosystems.
　 Statistical analysis. Data are expressed as 
means±standard deviation.  The groups were com-
pared by an analysis of variance with the Tukey-
Kramer test,  and diﬀerences were considered signiﬁ-
cant when the probability was less than 0.05.
Results
　 The arterial oxygen pressure (PaO2) levels in 
groups I and II were signiﬁcantly higher than those in 
groups III and IV (mean PaO2±standard deviation 
[SD] in group I,  II,  III,  and IV: 497.3±
95.6 mmHg,  543.3± 74.2 mmHg,  192.1±
103.0mmHg,  and 129.1±42.6mmHg,  respectively; p
＜0.0001,  respectively).  There were no signiﬁcant 
diﬀerences between groups I and II (p＝0.472) (Fig.  
1).  There were no signiﬁcant diﬀerences between the 
groups regarding the arterial carbon dioxide pressure 
(PaCO2) levels (mean PaCO2±SD in groups I,  II,  III,  
and IV: 40.8±8.0mmHg,  37.7±8.9mmHg,  41.9±
16.9mmHg,  and 24.2±19.8mmHg,  respectively).  The 
PAPs in groups I and II were signiﬁcantly lower than 
those of groups III and IV (mean PAP±SD in groups 
I,  II,  III,  and IV: 24.2±4.1mmHg,  24.8±
3.9mmHg,  36.4±8.6mmHg,  and 43.8±10.8mmHg,  
respectively; p＝0.0007 and p＜0.0001: group I vs.  
group III and IV; p＝0.0014 and p＜0.0001: group II 
vs.  group III and IV,  respectively).  There were no 
signiﬁcant diﬀerences between groups I and II (p＝
0.999) (Fig.  2).  The gene expression in group I was 
signiﬁcantly lower than in other groups and that in 
group II was signiﬁcantly higher than in group IV 
(mean relative gene expression level±SD in groups I,  
II,  III,  and IV: 0.330±0.156 relative units,  0.964±
0.246 relative units,  0.868±0.143 relative units,  and 
0.631±0.214 relative units,  respectively; p＜
0.0001,  p＜0.0001,  and p＝0.037: group I vs.  group 
II,  III,  and IV; p＝0.019: group II vs.  group IV) The 
diﬀerence between groups II and III was not statisti-
cally signiﬁcant (p＝0.812) (Fig.  3).  A histologic 
examination by a pathologist demonstrated that the 
graft lung tissue in groups III and IV showed higher 
degrees of severe injury to the lung parenchyma,  sug-
gesting the pathologic features of the lungs in acute 
respiratory distress syndrome (ARDS) (Fig.  4).  The 
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Fig. 1　 Arterial blood gas analysis.  Forty-eight h after lung 
transplantation the right main bronchus and the right main PA were 
ligated; 5min later,  the PaO2 of blood from those vessels was 
measured.  Data are shown as means±standard deviation.  (PaO2
＝arterial oxygen tension.  ＊indicates p＜0.01)
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alveolar ducts in group III appeared dilated as a result 
of the collapse and consolidation of adjacent alveoli.  
The graft in group IV showed a layering of the hyaline 
membranes on the alveolar septa.  On the other hand,  
the grafts in groups I and II showed only a slight 
degree of hemorrhaging and alveolar edema.
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Fig. 2　 Peak airway pressure.  Forty-eight h after lung transplan-
tation,  PAP was measured by polygraph for 5min after the ligation 
of the right main bronchus and the right main PA.  Data are shown 
as means±standard deviation.  (PAP,  peak airway pressure;
＊＊indicates p＜0.05.)
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Fig. 3　 Quantitative RT-PCR analysis of the expression of lacZ        
mRNA.  Lungs were transfected ex vivo,  stored for 4 hours at 4℃,  
10℃,  16℃,  and 23℃,  and transplanted.  The gene expression in 
the transplanted left lungs was assessed on postoperative day 2.  
Data are shown as means±standard deviation.  (RTﾝPCR＝
reverse transcription-polymerase chain reaction; ＊＊indicates p＜
0.05)
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Fig. 4　 Histologic ﬁndings of lung grafts tissue in (A) 4℃,  (B) 
10℃,  (C) 16℃,  (D) 23℃.  Forty-eight h after lung transplantation,  
rat lung grafts were extracted and stained with hematoxylin and 
eosin.  (Hematoxylin-eosin staining; original magniﬁcation×200.)
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Discussion
　 As gene therapy principles and practices have 
improved,  the application of gene therapy to trans-
plantation has now become feasible in the laboratory 
and it is being used to study the mechanisms of trans-
plantation tolerance,  as well as to explore new strate-
gies for tolerance induction.  Although transient 
expression is regarded as one of the drawbacks of 
current gene delivery systems,  this actually is desir-
able in the treatment of acute,  self-limited conditions 
such as ischemia-reperfusion injury [17].  On the 
other hand,  for chronic rejection,  it is important that 
transgene expression exhibit long-term stability and 
that liposome-DNA complexes are repeatedly adminis-
tered without inducing an inﬂammatory response.  A 
second administration of viral vector DNA is not eﬃ-
cient owing to a signiﬁcant inﬂammatory response,  
since the transduced cells express viral proteins and 
are promptly destroyed by the host immune system 
[18].  Canonico and associates [19] have demon-
strated that weekly intravenous or aerosol delivery of 
cationic liposome DNA complexes in rabbits resulted 
in sustained transgene expression and did not aﬀect 
lung histology,  mechanism,  or oxygenation.  
Therefore,  cationic liposomes may be a more suitable 
vector for the treatment of chronic rejection than viral 
vector.  This is the main reason that we chose cationic 
liposome as the vector for ex vivo transfection in this 
study.
　 In this study,  4 storage temperatures were chosen 
for the following reasons: 4℃ is the temperature 
currently used for human lung preservation.  Previous 
reports have insisted that the optimal preservation 
temperature is in the vicinity of 10℃ [20,  21].  The 
temperature of 23℃ is too warm to preserve the lung,  
but this group was included as previous studies have 
demonstrated that this temperature is good for trans-
fection [10],  and 16℃ is equal to the mean of 10℃ 
and 23℃.  Hypothermia is better for organ preserva-
tion than normothermia [20].  Currently,  4℃ is used 
as the storage temperature of lung grafts in clinical 
lung transplantation,  as determined through extensive 
research eﬀorts [22].  The higher the preservation 
temperature,  the more the grafts deteriorate,  as 
evidenced by a decreased PaO2 level and increased 
PAP in the present study.  A histologic examination in 
our study demonstrated that the grafts in groups III 
and IV showed pathologic features of the lung similar 
to those observed in ARDS.  There is no doubt that 
hypothermia is essential for ischemic organ preserva-
tion to slow the metabolic processes and maintain lung 
function; however,  transgene expression is inhibited 
by decreased temperature,  thus suggesting that the 
mechanism of nuclear import is energy dependent [9].  
It is well known that as the phospholipid bilayers 
become heated,  the membrane permeability to small 
molecules increases [23].  Therefore,  we anticipated 
that a higher preservation temperature would lead to 
higher transfection eﬃciency.  However,  the transfec-
tion eﬃciency was the highest in group II,  while the 
gene expression decreased in the groups at higher 
storage temperatures (groups III and IV),  perhaps due 
to an impairment of the graft tissue caused by both the 
warm temperature during preservation and ischemia-
reperfusion injury.  The very low transfection rate of 
group I was probably due to a signiﬁcant decrease of 
enzymatic activity in such hypothermic circumstances.
　 In summary,  we judged the optimal temperature of 
graft preservation after ex vivo gene transfer to be 
10℃,  balancing the considerations of lung injury and 
the eﬃciency of transgene expression.  Whether these 
levels of transgene expression are suﬃcient to produce 
beneﬁcial eﬀects in a graft still remains to be deter-
mined in future studies using functional genes,  and 
new vectors must overcome the problems associated 
with the lack of speciﬁc cell targeting in vivo,  low 
transfection frequencies,  and the lack of a long-term 
stable expression.
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